enoxacin has been researched along with Lung Diseases, Obstructive in 5 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The careful monitoring of serum theophylline level and modification of theophylline dosage in patients receiving enoxacin and theophylline were recommended." | 1.28 | [Effect of enoxacin on theophylline pharmacokinetics]. ( Liu, YN, 1992) |
| "Enoxacin is a safe and effective alternative to parenteral treatment of lower respiratory tract infections." | 1.27 | Enoxacin in the treatment of lower respiratory tract infections. ( Arnaud, A; Frances, Y; Nourrit, J; Philip-Joet, F, 1988) |
| " The patients were divided into 5 groups according with the timing of sampling: 1, 3, 6, 12 hours after dosing at day 3 (group I, II, III, IV), 3 hours after dosing at day 1, 2 and 3 (group V)." | 1.27 | [Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man]. ( Benard, Y; Malbruny, B; Morel, C; Vergnaud, M, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, YN | 1 |
| Philip-Joet, F | 1 |
| Nourrit, J | 1 |
| Frances, Y | 1 |
| Arnaud, A | 1 |
| Morel, C | 1 |
| Vergnaud, M | 1 |
| Malbruny, B | 1 |
| Benard, Y | 1 |
| Wijnands, WJ | 1 |
| Vree, TB | 1 |
| Van Herwaarden, CL | 1 |
5 other studies available for enoxacin and Lung Diseases, Obstructive
| Article | Year |
|---|---|
[Effect of enoxacin on theophylline pharmacokinetics].
Topics: Adult; Aged; Aminophylline; Drug Interactions; Enoxacin; Humans; Lung Diseases, Obstructive; Male; M | 1992 |
Enoxacin in the treatment of lower respiratory tract infections.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Chronic Disease; Drug | 1988 |
[Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man].
Topics: Aged; Diffusion; Enoxacin; Humans; Lung Diseases, Obstructive; Middle Aged; Naphthyridines; Sputum | 1987 |
[Enoxacin and theophylline].
Topics: Drug Interactions; Enoxacin; Humans; Lung Diseases, Obstructive; Naphthyridines; Theophylline | 1986 |
Enoxacin decreases the clearance of theophylline in man.
Topics: Adult; Aged; Depression, Chemical; Enoxacin; Female; Humans; Lung Diseases, Obstructive; Male; Middl | 1985 |